This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling
Communications Biology Open Access 23 October 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Stanford, S. M. et al. Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nat. Chem. Biol. http://dx.doi.org/10.1038/nchembio.2344 (2017)
Rights and permissions
About this article
Cite this article
Crunkhorn, S. Protein tyrosine phosphatase inhibitor reverses diabetes. Nat Rev Drug Discov 16, 312–313 (2017). https://doi.org/10.1038/nrd.2017.73
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.73
This article is cited by
-
Protein tyrosine phosphatases (PTPs) in diabetes: causes and therapeutic opportunities
Archives of Pharmacal Research (2021)
-
PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling
Communications Biology (2020)